Cantor Fitzgerald Reiterates Pfizer (PFE) at Overweight Rating with $75 PT on Phase 3 etrasimod Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. STUB
6. EAT
7. BTGO
8. NVDA
9. WYFI
10. ARX

Go back to Cantor Fitzgerald Reiterates Pfizer (PFE) at Overweight Rating with $75 PT on Phase 3 etrasimod Data
Pfizer Inc. (NYSE: PFE) Delayed: 26.80 +0.49 (1.86%)
Previous Close $26.31    52 Week High $37.39 
Open $26.49    52 Week Low $28.25 
Day High $26.95    P/E 16.24 
Day Low $26.41    EPS $1.65 
Volume 35,332,394